Additivity of inhibitory effects in multidrug combinations

Area of Science:

• Microbiology
• Pharmacology
• Systems Biology

Background:

• Cells frequently encounter drug mixtures in natural and clinical settings.
• Predicting combined drug effects relies on response additivity (Bliss) and dosage additivity (Loewe) models.
• These models diverge as the number of drugs increases.

Purpose of the Study:

• To compare Bliss and Loewe model predictions against experimental data.
• To investigate how drug combinations affect microbial growth across different species.
• To identify a more accurate model for predicting multi-drug effects.

Main Methods:

• Growth measurements of four diverse microorganisms (E. coli, S. aureus, E. faecalis, S. cerevisiae).
• Testing combinations of up to ten different drugs.
• Contrasting experimental results with Bliss and Loewe model predictions.

Main Results:

• Bliss additivity maintained accuracy with increasing drug numbers across all species.
• Loewe dosage additivity systematically lost predictive power.
• Required dosage for growth inhibition increased with drug number, following square-root scaling.

Conclusions:

• Effect additivity (Bliss) and dose-orthogonality provide a superior framework for multi-drug effects.
• Dosage additivity (Loewe) is inadequate for predicting combined drug actions with increasing complexity.
• Findings offer insights into how multiple drugs and stressors interact in biological systems.